Human Toll-like Receptor-dependent Induction of Interferons in Protective Immunity to Viruses

Overview

Journal Immunol Rev

Specialties Allergy & Immunology
General Surgery

Date 2007 Nov 6

PMID 17979850

Citations 69

Authors

Shen-Ying Zhang

Emmanuelle Jouanguy

Vanessa Sancho-Shimizu

Horst von Bernuth

Kun Yang

Laurent Abel

Capucine Picard

Anne Puel

Jean-Laurent Casanova

Affiliations

Soon will be listed here.

Abstract

Five of the 10 human Toll-like receptors (TLRs) (TLR3, TLR4, TLR7, TLR8, and TLR9), and four of the 12 mouse TLRs (TLR3, TLR4, TLR7, TLR9) can trigger interferon (IFN)-alpha, IFN-beta, and IFN-lambda, which are critical for antiviral immunity. Moreover, TLR3, TLR7, TLR8, and TLR9 differ from TLR4 in two particularly important ways for antiviral immunity: they can be activated by nucleic acid agonists mimicking compounds produced during the viral cycle, and they are typically present within the cell, along the endocytic pathway, where they sense viral products in the intraluminal space. Investigations in mice have demonstrated that the TLR7/9-IFN and TLR3-IFN pathways are different and critical for protective immunity to various experimental viral infections. Investigations in humans with interleukin-1 receptor-associated kinase-4 (IRAK-4) deficiency (unresponsive to TLR7, TLR8, and TLR9), UNC-93B deficiency (unresponsive to TLR3, TLR7, TLR8, and TLR9), and TLR3 deficiency have recently shed light on the role of these two pathways in antiviral immunity in natural conditions. UNC-93B- and TLR3-deficient patients appear to be specifically prone to herpes simplex virus 1 (HSV-1) encephalitis, although clinical penetrance is incomplete, whereas IRAK-4-deficient patients appear to be normally resistant to most viruses, including HSV-1. These experiments of nature suggest that the TLR7-, TLR8-, and TLR9-dependent induction of IFN-alpha, IFN-beta, and IFN-lambda is largely redundant in human antiviral immunity, whereas the TLR3-dependent induction of IFN-alpha, IFN-beta, and IFN-lambda is critical for primary immunity to HSV-1 in the central nervous system in children but redundant for immunity to most other viral infections.

Citing Articles

An interferon-stimulated long non-coding RNA USP30-AS1 as an immune modulator in influenza A virus infection.

Cao Y, Chin A, Gu H, Li M, Gu Y, Lau S PLoS Pathog. 2025; 21(1):e1012854.

PMID: 39777915 PMC: 11750089. DOI: 10.1371/journal.ppat.1012854.

The role of viral infection in implantation failure: direct and indirect effects.

Rezaei M, Moghoofei M Reprod Biol Endocrinol. 2024; 22(1):142.

PMID: 39529140 PMC: 11552308. DOI: 10.1186/s12958-024-01303-w.

Viral entry mechanisms: the role of molecular simulation in unlocking a key step in viral infections.

Valerio M, Buga C, Melo M, Soares C, Lousa D FEBS Open Bio. 2024; 15(2):269-284.

PMID: 39402013 PMC: 11788750. DOI: 10.1002/2211-5463.13908.

The emerging roles of protein arginine methyltransferases in antiviral innate immune signaling pathways.

Nie H, Li Q, Pan W Front Microbiol. 2023; 14:1322929.

PMID: 38116532 PMC: 10728285. DOI: 10.3389/fmicb.2023.1322929.

First-in-Human Study of the Safety, Pharmacokinetics, and Pharmacodynamics of MHV370, a Dual Inhibitor of Toll-Like Receptors 7 and 8, in Healthy Adults.

Shisha T, Posch M, Lehmann J, Feifel R, Junt T, Hawtin S Eur J Drug Metab Pharmacokinet. 2023; 48(5):553-566.

PMID: 37532923 PMC: 10480294. DOI: 10.1007/s13318-023-00847-3.

References

Heinz S, Haehnel V, Karaghiosoff M, Schwarzfischer L, Muller M, Krause S . Species-specific regulation of Toll-like receptor 3 genes in men and mice. J Biol Chem. 2003; 278(24):21502-9. DOI: 10.1074/jbc.M301476200. View

Fitzgerald K, Palsson-McDermott E, Bowie A, Jefferies C, Mansell A, Brady G . Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction. Nature. 2001; 413(6851):78-83. DOI: 10.1038/35092578. View

Yoneyama M, Kikuchi M, Natsukawa T, Shinobu N, Imaizumi T, Miyagishi M . The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol. 2004; 5(7):730-7. DOI: 10.1038/ni1087. View

Ku C, von Bernuth H, Picard C, Zhang S, Chang H, Yang K . Selective predisposition to bacterial infections in IRAK-4-deficient children: IRAK-4-dependent TLRs are otherwise redundant in protective immunity. J Exp Med. 2007; 204(10):2407-22. PMC: 2118442. DOI: 10.1084/jem.20070628. View

Zhou S, Kurt-Jones E, Mandell L, Cerny A, Chan M, Golenbock D . MyD88 is critical for the development of innate and adaptive immunity during acute lymphocytic choriomeningitis virus infection. Eur J Immunol. 2005; 35(3):822-30. DOI: 10.1002/eji.200425730. View

Dhara A, Saini M, Das D, Swarup D, Sharma B, Kumar S . Molecular characterization of coding sequences and analysis of Toll-like receptor 3 mRNA expression in water buffalo (Bubalus bubalis) and nilgai (Boselaphus tragocamelus). Immunogenetics. 2006; 59(1):69-76. DOI: 10.1007/s00251-006-0174-6. View

Zhang D, Zhang G, Hayden M, Greenblatt M, Bussey C, Flavell R . A toll-like receptor that prevents infection by uropathogenic bacteria. Science. 2004; 303(5663):1522-6. DOI: 10.1126/science.1094351. View

Kuchtey J, Chefalo P, Gray R, Ramachandra L, Harding C . Enhancement of dendritic cell antigen cross-presentation by CpG DNA involves type I IFN and stabilization of class I MHC mRNA. J Immunol. 2005; 175(4):2244-51. DOI: 10.4049/jimmunol.175.4.2244. View

Jain A, Ma C, Liu S, Brown M, Cohen J, Strober W . Specific missense mutations in NEMO result in hyper-IgM syndrome with hypohydrotic ectodermal dysplasia. Nat Immunol. 2001; 2(3):223-8. DOI: 10.1038/85277. View

10.

Meylan E, Burns K, Hofmann K, Blancheteau V, Martinon F, Kelliher M . RIP1 is an essential mediator of Toll-like receptor 3-induced NF-kappa B activation. Nat Immunol. 2004; 5(5):503-7. DOI: 10.1038/ni1061. View

11.

Yamamoto M, Sato S, Hemmi H, Hoshino K, Kaisho T, Sanjo H . Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science. 2003; 301(5633):640-3. DOI: 10.1126/science.1087262. View

12.

Bsibsi M, Ravid R, Gveric D, van Noort J . Broad expression of Toll-like receptors in the human central nervous system. J Neuropathol Exp Neurol. 2002; 61(11):1013-21. DOI: 10.1093/jnen/61.11.1013. View

13.

Rock F, Hardiman G, Timans J, Kastelein R, Bazan J . A family of human receptors structurally related to Drosophila Toll. Proc Natl Acad Sci U S A. 1998; 95(2):588-93. PMC: 18464. DOI: 10.1073/pnas.95.2.588. View

14.

Suzuki N, Saito T . IRAK-4--a shared NF-kappaB activator in innate and acquired immunity. Trends Immunol. 2006; 27(12):566-72. DOI: 10.1016/j.it.2006.10.003. View

15.

Wang T, Town T, Alexopoulou L, Anderson J, Fikrig E, Flavell R . Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat Med. 2004; 10(12):1366-73. DOI: 10.1038/nm1140. View

16.

de la Cruz I, Levin J, Cummins C, Anderson P, Horvitz H . sup-9, sup-10, and unc-93 may encode components of a two-pore K+ channel that coordinates muscle contraction in Caenorhabditis elegans. J Neurosci. 2003; 23(27):9133-45. PMC: 6740817. View

17.

Rudd B, Smit J, Flavell R, Alexopoulou L, Schaller M, Gruber A . Deletion of TLR3 alters the pulmonary immune environment and mucus production during respiratory syncytial virus infection. J Immunol. 2006; 176(3):1937-42. DOI: 10.4049/jimmunol.176.3.1937. View

18.

Uematsu S, Sato S, Yamamoto M, Hirotani T, Kato H, Takeshita F . Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR)7- and TLR9-mediated interferon-{alpha} induction. J Exp Med. 2005; 201(6):915-23. PMC: 2213113. DOI: 10.1084/jem.20042372. View

19.

Sun Y, Leaman D . Ectopic expression of toll-like receptor-3 (TLR-3) overcomes the double-stranded RNA (dsRNA) signaling defects of P2.1 cells. J Interferon Cytokine Res. 2004; 24(6):350-61. DOI: 10.1089/107999004323142213. View

20.

Stetson D, Medzhitov R . Recognition of cytosolic DNA activates an IRF3-dependent innate immune response. Immunity. 2006; 24(1):93-103. DOI: 10.1016/j.immuni.2005.12.003. View